AstraZeneca PLC (AZN)

Industry Drug Manufacturers - General
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

11,244.00p

Buy

11,248.00p

arrow-down-0.84p (-0.01%)

Prices updated at 23 Apr 2024, 09:41 BST
| Prices minimum 15 mins delay
|
Prices in GBX
AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.
FTSE All-Share
arrow-up0.25%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Income statement

Year
chevron-l-regular
chevron-r-regular
20222023
44,351m45,811m
31,960m37,543m
4,512m8,722m
10.1719.04
3,288m5,955m
9,085m13,422m
Sales, General and administrative17,984m18,222m
Interest expenses1,330m1,589m
Provision for income taxes-792m938m
Operating expenses27,448m28,821m
Income before taxes2,501m6,899m
Net income available to common shareholders3,288m5,955m
2.123.84
Net interest income-1,249m-1,288m
Advertising and promotion--
Net investment income, net-16m-34m
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)2.113.81
Free cash flow per share3.2393.5128
Book value/share18.80618.8467
Debt equity ratio0.6396310.593261

Balance sheet

Year
chevron-l-regular
chevron-r-regular
20222023
Current assets22,593m25,054m
Current liabilities26,293m30,542m
Total capital60,002m61,508m
Total debt29,232m28,622m
Total equity37,037m39,143m
Total non current liabilities--
Loans22,965m22,365m
Total assets96,483m101,119m
Total liabilities--
Cash and cash equivalents6,166m5,840m
Common stock1,550m1,550m

Cash flow

Year
chevron-l-regular
chevron-r-regular
20222023
Cash at beginning of period6,038m5,983m
Cash dividends paid-4,364m-4,481m
7,237m6,567m
Investments (gains) losses-2,960m-4,064m
5,983m5,637m
Net income--
9,808m10,345m
-2,571m-3,778m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.